Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rao

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Cell and Developmental Biology|February 11, 2020
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized ImmunotherapiesJoana R Lérias, Georgia Paraschoudi, Eric de Sousa, et al.
Ebiomedicine|July 28, 2018
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma MultiformeLiu Zhenjiang, Martin Rao, Xiaohua Luo, et al.
Frontiers in Immunology|August 2, 2021
Targeting Neoepitopes to Treat Solid Malignancies: ImmunosurgeryEric de Sousa, Joana R Lérias, Antonio Beltran, et al.
The Lancet. Infectious Diseases|March 28, 2018
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapiesSimon Tiberi, Nelita du Plessis, Gerhard Walzl, et al.
Frontiers in Microbiology|January 31, 2020
Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future OpportunitiesJoana R Lérias, Eric de Sousa, Georgia Paraschoudi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomasMaría A Duque-Correa, Anja A Kühl, Paulo C Rodriguez, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 25, 2018
Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB"Simon Tiberi, Eskild Petersen, Markus Maeurer, et al.
Science Translational Medicine|May 22, 2024
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6Christiane R Stadler, Ursula Ellinghaus, Leyla Fischer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2019
World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme SeriesEskild Petersen, Martin Rao, Giuseppe Ippolito, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Cell and Developmental Biology|February 11, 2020
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized ImmunotherapiesJoana R Lérias, Georgia Paraschoudi, Eric de Sousa, et al.
Ebiomedicine|July 28, 2018
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma MultiformeLiu Zhenjiang, Martin Rao, Xiaohua Luo, et al.
Frontiers in Immunology|August 2, 2021
Targeting Neoepitopes to Treat Solid Malignancies: ImmunosurgeryEric de Sousa, Joana R Lérias, Antonio Beltran, et al.
The Lancet. Infectious Diseases|March 28, 2018
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapiesSimon Tiberi, Nelita du Plessis, Gerhard Walzl, et al.
Frontiers in Microbiology|January 31, 2020
Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future OpportunitiesJoana R Lérias, Eric de Sousa, Georgia Paraschoudi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomasMaría A Duque-Correa, Anja A Kühl, Paulo C Rodriguez, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 25, 2018
Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB"Simon Tiberi, Eskild Petersen, Markus Maeurer, et al.
Science Translational Medicine|May 22, 2024
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6Christiane R Stadler, Ursula Ellinghaus, Leyla Fischer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2019
World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme SeriesEskild Petersen, Martin Rao, Giuseppe Ippolito, et al.
Pageof 6